Biohit Oyj logo

BIOBV - Biohit Oyj Share Price

€2.14 0.0  0.9%

Last Trade - 27/03/20

Sector
Healthcare
Size
Micro Cap
Market Cap £28.8m
Enterprise Value £20.7m
Revenue £9.03m
Position in Universe 1002nd / 1733
Bullish
Bearish
Unlock BIOBV Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BIOBV Revenue Unlock BIOBV Revenue

Net Income

BIOBV Net Income Unlock BIOBV Revenue

Normalised EPS

BIOBV Normalised EPS Unlock BIOBV Revenue

PE Ratio Range

BIOBV PE Ratio Range Unlock BIOBV Revenue

Dividend Yield Range

BIOBV Dividend Yield Range Unlock BIOBV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BIOBV EPS Forecasts Unlock BIOBV Revenue
Profile Summary

Biohit Oyj is a Finland-based company engaged in the development, manufacture and marketing of diagnostic tests and analysis systems. The Company operates one business segment, named Diagnostics. The Diagnostics segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases. It provides blood-sample examination based on GastroPanel for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, as well as the ColonView examination for the early detection of fecal occult intestinal bleeding, which indicates a risk of colorectal cancer. The Company’s products are used in hospitals, healthcare centers and research institutions. It operates primarily in Europe and Asia. Furthermore, the Company is a parent of Biohit Healthcare Ltd, Biohit Healthcare Srl, Oy Finio Ab, and Vantaan Hienomekano Oy, among others.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated March 9, 1988
Public Since June 18, 1999
No. of Shareholders: n/a
No. of Employees: 42
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange OMX Nordic Exchange - Helsinki
Shares in Issue 15,045,593
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BIOBV Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BIOBV
Upcoming Events for BIOBV
Wednesday 22nd April, 2020
Biohit Oyj Annual Shareholders Meeting
Similar to BIOBV
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.